Antecedent Aspirin Use Is Associated with Less Severe Symptoms on Admission for Ischemic Stroke

Sarah Nelson, Lisa Cloonan, Allison S. Kanakis, Kaitlin M. Fitzpatrick, Kelsey I. Shideler, Adriana S. Perilla, Karen L. Furie, Natalia S. Rost

Research output: Contribution to journalArticle

Abstract

Background Aspirin is known to reduce stroke risk; however, its role in reducing severity of ischemic syndrome is not clear. We sought to investigate the relationship between antecedent aspirin use and stroke severity in patients presenting with acute ischemic stroke (AIS). Methods We retrospectively analyzed a prospectively collected database of consecutive AIS patients presenting to our center. Clinical characteristics (including antecedent aspirin use), imaging findings, and laboratory data were assessed in association with presenting stroke severity, as measured by the National Institutes of Health Stroke Scale (NIHSS). Logistic regression models were used to determine univariate and multivariate predictors of baseline NIHSS. Results Of the 610 AIS patients with admission brain magnetic resonance imaging available for volumetric analysis of acute infarct size, 241 (39.5%) used aspirin prior to stroke onset. Antecedent aspirin use (P = .0005), history of atrial fibrillation (P < .0001), acute infarct volume (P < .0001), initial systolic blood pressure (P = .041), admission glucose level (P = .0027), and stroke subtype (P < .0001) were associated with presenting stroke severity in univariate analysis. Antecedent aspirin use (P < .0001), history of atrial fibrillation (P < .0002), acute infarct volume (P < .0001), systolic blood pressure (P = .038), and glucose level (P = .0095) remained independent predictors of NIHSS in multivariable analysis. Conclusions Antecedent aspirin use was independently associated with milder presenting stroke severity, even after accounting for acute infarct volume. While the underlying biology of this apparent protective relationship requires further study, patients at high risk of stroke may benefit from routine aspirin use.

Original languageEnglish (US)
Pages (from-to)2519-2525
Number of pages7
JournalJournal of Stroke and Cerebrovascular Diseases
Volume25
Issue number10
DOIs
StatePublished - Oct 1 2016
Externally publishedYes

Fingerprint

Aspirin
Stroke
National Institutes of Health (U.S.)
Blood Pressure
Atrial Fibrillation
Logistic Models
Glucose
Patient Admission
Magnetic Resonance Imaging
Databases

Keywords

  • aspirin
  • atrial fibrillation
  • blood pressure
  • Brain infarction
  • glucose

ASJC Scopus subject areas

  • Surgery
  • Rehabilitation
  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine

Cite this

Antecedent Aspirin Use Is Associated with Less Severe Symptoms on Admission for Ischemic Stroke. / Nelson, Sarah; Cloonan, Lisa; Kanakis, Allison S.; Fitzpatrick, Kaitlin M.; Shideler, Kelsey I.; Perilla, Adriana S.; Furie, Karen L.; Rost, Natalia S.

In: Journal of Stroke and Cerebrovascular Diseases, Vol. 25, No. 10, 01.10.2016, p. 2519-2525.

Research output: Contribution to journalArticle

Nelson, Sarah ; Cloonan, Lisa ; Kanakis, Allison S. ; Fitzpatrick, Kaitlin M. ; Shideler, Kelsey I. ; Perilla, Adriana S. ; Furie, Karen L. ; Rost, Natalia S. / Antecedent Aspirin Use Is Associated with Less Severe Symptoms on Admission for Ischemic Stroke. In: Journal of Stroke and Cerebrovascular Diseases. 2016 ; Vol. 25, No. 10. pp. 2519-2525.
@article{28c27308c3a64a57a10aa707773a0241,
title = "Antecedent Aspirin Use Is Associated with Less Severe Symptoms on Admission for Ischemic Stroke",
abstract = "Background Aspirin is known to reduce stroke risk; however, its role in reducing severity of ischemic syndrome is not clear. We sought to investigate the relationship between antecedent aspirin use and stroke severity in patients presenting with acute ischemic stroke (AIS). Methods We retrospectively analyzed a prospectively collected database of consecutive AIS patients presenting to our center. Clinical characteristics (including antecedent aspirin use), imaging findings, and laboratory data were assessed in association with presenting stroke severity, as measured by the National Institutes of Health Stroke Scale (NIHSS). Logistic regression models were used to determine univariate and multivariate predictors of baseline NIHSS. Results Of the 610 AIS patients with admission brain magnetic resonance imaging available for volumetric analysis of acute infarct size, 241 (39.5{\%}) used aspirin prior to stroke onset. Antecedent aspirin use (P = .0005), history of atrial fibrillation (P < .0001), acute infarct volume (P < .0001), initial systolic blood pressure (P = .041), admission glucose level (P = .0027), and stroke subtype (P < .0001) were associated with presenting stroke severity in univariate analysis. Antecedent aspirin use (P < .0001), history of atrial fibrillation (P < .0002), acute infarct volume (P < .0001), systolic blood pressure (P = .038), and glucose level (P = .0095) remained independent predictors of NIHSS in multivariable analysis. Conclusions Antecedent aspirin use was independently associated with milder presenting stroke severity, even after accounting for acute infarct volume. While the underlying biology of this apparent protective relationship requires further study, patients at high risk of stroke may benefit from routine aspirin use.",
keywords = "aspirin, atrial fibrillation, blood pressure, Brain infarction, glucose",
author = "Sarah Nelson and Lisa Cloonan and Kanakis, {Allison S.} and Fitzpatrick, {Kaitlin M.} and Shideler, {Kelsey I.} and Perilla, {Adriana S.} and Furie, {Karen L.} and Rost, {Natalia S.}",
year = "2016",
month = "10",
day = "1",
doi = "10.1016/j.jstrokecerebrovasdis.2016.06.032",
language = "English (US)",
volume = "25",
pages = "2519--2525",
journal = "Journal of Stroke and Cerebrovascular Diseases",
issn = "1052-3057",
publisher = "W.B. Saunders Ltd",
number = "10",

}

TY - JOUR

T1 - Antecedent Aspirin Use Is Associated with Less Severe Symptoms on Admission for Ischemic Stroke

AU - Nelson, Sarah

AU - Cloonan, Lisa

AU - Kanakis, Allison S.

AU - Fitzpatrick, Kaitlin M.

AU - Shideler, Kelsey I.

AU - Perilla, Adriana S.

AU - Furie, Karen L.

AU - Rost, Natalia S.

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Background Aspirin is known to reduce stroke risk; however, its role in reducing severity of ischemic syndrome is not clear. We sought to investigate the relationship between antecedent aspirin use and stroke severity in patients presenting with acute ischemic stroke (AIS). Methods We retrospectively analyzed a prospectively collected database of consecutive AIS patients presenting to our center. Clinical characteristics (including antecedent aspirin use), imaging findings, and laboratory data were assessed in association with presenting stroke severity, as measured by the National Institutes of Health Stroke Scale (NIHSS). Logistic regression models were used to determine univariate and multivariate predictors of baseline NIHSS. Results Of the 610 AIS patients with admission brain magnetic resonance imaging available for volumetric analysis of acute infarct size, 241 (39.5%) used aspirin prior to stroke onset. Antecedent aspirin use (P = .0005), history of atrial fibrillation (P < .0001), acute infarct volume (P < .0001), initial systolic blood pressure (P = .041), admission glucose level (P = .0027), and stroke subtype (P < .0001) were associated with presenting stroke severity in univariate analysis. Antecedent aspirin use (P < .0001), history of atrial fibrillation (P < .0002), acute infarct volume (P < .0001), systolic blood pressure (P = .038), and glucose level (P = .0095) remained independent predictors of NIHSS in multivariable analysis. Conclusions Antecedent aspirin use was independently associated with milder presenting stroke severity, even after accounting for acute infarct volume. While the underlying biology of this apparent protective relationship requires further study, patients at high risk of stroke may benefit from routine aspirin use.

AB - Background Aspirin is known to reduce stroke risk; however, its role in reducing severity of ischemic syndrome is not clear. We sought to investigate the relationship between antecedent aspirin use and stroke severity in patients presenting with acute ischemic stroke (AIS). Methods We retrospectively analyzed a prospectively collected database of consecutive AIS patients presenting to our center. Clinical characteristics (including antecedent aspirin use), imaging findings, and laboratory data were assessed in association with presenting stroke severity, as measured by the National Institutes of Health Stroke Scale (NIHSS). Logistic regression models were used to determine univariate and multivariate predictors of baseline NIHSS. Results Of the 610 AIS patients with admission brain magnetic resonance imaging available for volumetric analysis of acute infarct size, 241 (39.5%) used aspirin prior to stroke onset. Antecedent aspirin use (P = .0005), history of atrial fibrillation (P < .0001), acute infarct volume (P < .0001), initial systolic blood pressure (P = .041), admission glucose level (P = .0027), and stroke subtype (P < .0001) were associated with presenting stroke severity in univariate analysis. Antecedent aspirin use (P < .0001), history of atrial fibrillation (P < .0002), acute infarct volume (P < .0001), systolic blood pressure (P = .038), and glucose level (P = .0095) remained independent predictors of NIHSS in multivariable analysis. Conclusions Antecedent aspirin use was independently associated with milder presenting stroke severity, even after accounting for acute infarct volume. While the underlying biology of this apparent protective relationship requires further study, patients at high risk of stroke may benefit from routine aspirin use.

KW - aspirin

KW - atrial fibrillation

KW - blood pressure

KW - Brain infarction

KW - glucose

UR - http://www.scopus.com/inward/record.url?scp=84994844589&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994844589&partnerID=8YFLogxK

U2 - 10.1016/j.jstrokecerebrovasdis.2016.06.032

DO - 10.1016/j.jstrokecerebrovasdis.2016.06.032

M3 - Article

C2 - 27444522

AN - SCOPUS:84994844589

VL - 25

SP - 2519

EP - 2525

JO - Journal of Stroke and Cerebrovascular Diseases

JF - Journal of Stroke and Cerebrovascular Diseases

SN - 1052-3057

IS - 10

ER -